Your paper should cover the following topics: Define Ms. K with a short paragraph using the 4 D's (Deviance, Distress, Dysfunction, and Danger) Assess her depression from the video content and comment on her mood and possible diagnostic impressions you have Do you believe Ms. K is depressed? What are your diagnostic impressions? What is your DSM diagnosis and code (some small assumptions may be needed). Complete the MMSE, watch the videos, and score Ms. K using the instrument. Report the score and your impressions. Please use this link to access the instrument for Assignment 1. Score Ms. K using this instrument. Submit your MMSE with your paper. The Folstein Mini-Mental State Examination (MMSE) is a brief, 30 point questionnaire that is used to screen for cognitive impairment. It is commonly used in medicine to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. In about ten (10) minutes, it samples functions including arithmetic, memory, and orientation. It was introduced by Folstein et al. in 1975. The MMSE is the most commonly used test for complaints of memory problems. It can be used by clinicians to help diagnose dementia and to help assess its progression and severity. In general, scores of 27 or above (out of 30) are considered normal. However, getting a score below this does not always mean that a person has dementia - their mental abilities might be impaired for another reason, or they may have a physical problem such as difficulty hearing, which makes it harder for them to take the test. The MMSE can also be used to assess changes in a person who has already been diagnosed with dementia. It can help to give an indication of how severe a person's symptoms are and how quickly their dementia is progressing. On average, people with a diagnosis of Alzheimer's who are not receiving treatment will lose two to four MMSE points each year. The MMSE score is one of the things a doctor considers when deciding if pharmaceuticals will help a person with a diagnosis of dementia. The severity of the dementia gives an indication of which drugs may be of benefit. Recommendations as to which drugs may be used at each stage of dementia are issued by the National Institute for Health and Clinical Excellence (NICE). A score of 10-26 indicates mild-to-moderate Alzheimer's disease. A score less than 10 indicates severe Alzheimer's disease. It is important to note that a person's MMSE score can be affected by their level of education. This is because for highly educated people, the questions may be too easy. For those without the same level of education, the questions posed may be more difficult. This means that a highly educated person with mild dementia may score in the normal range, whereas a poorly educated person with no problems in cognition may score in the dementia range as well. For people with learning disabilities, difficulty speaking, or for those who are not fluent enough in a language in which the MMSE can be given, a different method should be used to assess dementia severity when treatment is being considered.